Weight Loss News Center
|
|
Weight Control News & InformationControversial diet drug Rimonabant now available on the NHS in Britain (News-Medical-Net)A controversial diet drug has been approved for use on the National Health Service (NHS) in Britain.Controversial obesity drug gets UK okay (Reuters via Yahoo! News) Sanofi-Aventis won a final green light for its obesity drug Acomplia from Britain's cost-effectiveness watchdog NICE on Wednesday, clearing the way for doctors to prescribe it on the state health service. Controversial obesity drug gets final okay (Reuters via Yahoo! UK & Ireland News)Sanofi-Aventis won a final green light for its obesity drug Acomplia from cost-effectiveness watchdog NICE on Wednesday, clearing the way for doctors to prescribe it on the state health service. NHS approves weight-loss drug banned in America over suicide fears (Evening Standard)A weight-loss drug banned in the U.S. over fears it can heighten the risk of suicide has been given the go-ahead in Britain. Acomplia will be available to overweight or obese patients who cannot take, or who have had no success with, the two other weight-loss drugs available on the Health Service. NHS approves weight-loss drug banned in America over suicide fears (Daily Mail)A weight-loss drug banned in the U.S. over fears it can heighten the risk of suicide has been given the go-ahead in Britain. Acomplia will be available to overweight or obese patients. Obesity drug rejected by Scottish NHS to be available in England and Wales (The Herald)An obesity drug rejected for use by the Scottish NHS will be available on prescription in England and Wales. Early trials have shown the treatment rimonabant, which suppresses appetite, could help patients lose up to 10% of their body weight. U.K. OKs Suicide-Linked Weight-Loss Drug (ABC News)The controversial drug Acomplia wins approval in Britain despite past problems. One pill to make you slimmer? (Provo Daily Herald)For an activity that seems to come so naturally to so many Americans, getting fat is actually quite complicated. Not surprisingly, then, so is developing a pill that will help reverse that process.
| |